-
January 15, 2020 Launch of the brand new « Fonds vaccin thérapeutique contre le cancer »
A few weeks ago, Dr. Robert Patenaude, who has been a chronic myeloid leukemia survivor for almost 40 years thanks to the great care and determination of Dr. Claude Perreault, announced the creation of the brand new Fonds vaccin thérapeutique contre le cancer, along with his generous $25,000 donation. The fund is intended to support the investigators involved in the project, namely the team led by Dr. Claude Perreault, in collaboration with the teams led by Sébastien Lemieux and Pierre Thibault, who work tirelessly and with conviction to change the life of people affected by cancer.
![]()
-
January 13, 2020 Vimentin: filaments whose role is far from trivial
A collaboration between European investigators and the team led by Philippe Roux of IRIC resulted in discovering the unsuspected role of vimentin intermediate filaments in cell division. That discovery is now the subject of an article in the prestigious scientific journal Developmental Cell.
![]()
-
November 22, 2019 The project led by Michel Bouvier and Domain Therapeutics with the support of CQDM is awarded the RSRI Recognition Award at the ADRIQ Innovation Prize Gala
CQDM is proud to announce that the project led by Michel Bouvier from the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal and the biotech Domain Therapeutics was awarded the RSRI Recognition Award during the ADRIQ Innovation Prize Gala held on November 21st.
![]()
-
November 20, 2019 A $100,000 donation for IRIC fellowships
IRIC is proud that it can count on the tremendous support of Mrs. Rita Baumgartner and Mr. Aldo Baumgartner, who recently announced a $100,000 donation specifically earmarked for fellowships.
![]()
-
November 4, 2019 Blood cancers: a “new generation” stem cell transplant significantly reduces complications for patients
In a Phase One-Two clinical trial, the great majority of patients with blood cancers are on the road to recovery, thanks to the UM171 molecule, discovered at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal.
![]()
-
January 15, 2020 The testimonial of Robert Patenaude
In 1980, over 100% of patients suffering from leukemias would die within two years. At that time, bone marrow transplants were just beginning on an experimental basis and were only being offered to young leukemia patients who had compatible donors. The cure rate was somewhere around 20%, with most patients dying from relapses, severe rejection reactions, infections or hemorrhaging.
During that same time, while I was a second year medical student, during a routine physical, it was discovered that I was severely anemic… -
January 9, 2020 A project carried out by IRIC research teams nominated by Québec Science
As we begin 2020, IRIC is very proud to announce that the project from the team headed by Dr. Claude Perreault, aimed at developing a therapeutic cancer vaccine, has been nominated as one of the 10 most impressive Quebec discoveries of the past year, a list put forward by Québec Science. The project was carried out in collaboration with the teams headed by Sébastien Lemieux and Pierre Thibault, who are also Principal Investigators at IRIC.
-
December 13, 2019 A potato virus helps uncover a new regulation mode for gene expression
The team led by Katherine L.B. Borden of IRIC, and spearheaded by Drs. Coutinho, Volpon, Culjkovic-Kraljacic and Osborne, accomplished nothing short of discovering a new mode of regulation and possibly production of proteins in cells. Curiously, this finding resulted from a protein structure from a virus that attacks, of all things, potatoes! Investigators unveiled their story in an article published in Proceedings of the National Academy of Sciences of the United States of America (P.N.A.S.).
-
November 14, 2019 Planned donation from Michel Bouvier and Muriel Aubry
On this National Philanthropy Day, IRIC salutes the exceptional commitment made by its Chief Executive Officer, Prof. Michel Bouvier, and his partner, Prof. Muriel Aubry, by announcing their testamentary donation in support of the Université de Montréal and the Institute for Research in Immunology and Cancer (IRIC).
-
October 28, 2019 Anne Marinier receives the Prix d’excellence 2019 des diplômés de l’UQAR
Anne Marinier, Principal Investigator and Director of Medicinal Chemistry at IRIC, has been awarded the Prix d’excellence des diplômés de l’Université du Québec à Rimouski (UQAR). This prestigious distinction was bestowed upon her on Saturday, October 26, 2019, at the official ceremony held at the Hôtel Rimouski – Centre des congrès…
-
September 20, 2019 Shedding light on new mechanisms related to cell migration
IRIC Investigators have made major discoveries involving the mechanisms regulating collective cell migration. Notably, this type of displacement is used by cancer cells that break away from a primary tumor to colonize another part of the body and form metastases…
-
September 13, 2019 Speeding up the drug discovery process to help patients: Michel Bouvier co-senior author of a study published in Nature Communications
An international research team has developed a new strategy that can predict the potential clinical implications of new therapeutic compounds based on simple cellular responses. This discovery was partly led by scientists affiliated with Université de Montréal (UdeM), and represents a major step forward in developing more effective drugs with fewer side effects, much faster than before. The researchers conducted their work at Centre de Recherche de l’Hôpital Ste-Justine and published their findings in the prestigious journal Nature Communications.
-
September 6, 2019 Mrs. Élaine and Mr. Réal Raymond once again show their commitment by donating $100,000 in support of Brian Wilhelm’s research
IRIC is proud to announce a $100,000 donation from Mrs. Élaine and Mr. Réal Raymond in support of Brian Wilhelm’s research in pediatric leukemia.
The couple renews its philanthropic commitment… -
September 6, 2019 IRIC on the road: 2019 student recruitment tour
The Academic Affairs team will once again take part this fall in the IRIC on the road student recruitment tour by participating in many graduate studies fairs held by various Canadian universities.
These recruitment activities provide students with a valuable opportunity to meet… -
July 8, 2019 $110,250 raised at the 10th Blais Family Fund Golf Tournament to benefit IRIC
On Friday, July 5, 2019, 225 people gathered at the Buckingham Golf Club for the 10th Blais Family Fund Golf Tournament. A record amount of $110,250 was raised to support cancer research efforts carried out at IRIC. Pierre Blais, he himself a leukemia survivor, thanks to an experimental treatment suggested by Dr. Guy Sauvageau, Principal Investigator at IRIC, is the driving force behind the event, which every year brings together family and friends devoted to the cause.
-
July 1, 2019 IRIC Student Recruitment Event 2019
The IRIC Student Recruitment Event offers students interested in pursuing graduate studies in the field of cancer research a unique opportunity to participate in an international student recruitment event at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal. The 2019 edition took place from June 12th to 14th, 2019.
-
June 28, 2019 $150,000 in funding from the Richard and Edith Strauss Foundation for two promising cancer research projects
IRIC is proud to announce $150,000 in funding from the Richard and Edith Strauss Foundation for two promising cancer research projects. For the “Identification of biological targets influencing the response to anti-AML drugs” project, Dr. Guy Sauvageau received $100,000 in funding. As for Dr. Sonia Cellot, Paediatric hematologist at CHU Sainte-Justine, and Brian Wilhelm, they received $50,000 in financial support for their project titled “Characterising the stem/progenitor cell of origin of high fatality pediatric leukemia”.